Biochemical profiles for severity on admission and management, complications and outcomes of DKA management by type of diabetes
| Parameters | Type 1 diabetes, median (Q1–Q3); n | Type 2 diabetes, median (Q1–Q3); n | Significance, p value |
| pH | 7.22 (7.09–7.29); 270 | 7.24 (7.11–7.30); 91 | 0.3266 |
| Bicarbonate (mmol/L) | 11.9 (7.1–16.8); 270 | 13.20 (7.8–17.8); 91 | 0.2192 |
| Glucose (mmol/L) | 28.00 (20.5–34.8); 274 | 26.55 (16.2–35.1); 92 | 0.4496 |
| Lactate (mmol/L) | 2.6 (1.8–4.3); 275 | 2.6 (2.0–4.2); 91 | 0.6532 |
| Serum osmolality (mOsm/L) | 310.1 (300.6–320.9); 275 | 312.1 (300.1–328.8); 92 | 0.2787 |
| Urea (mmol/L) | 7.1 (5.1–10.6); 279 | 8.9 (6.4–16.8); 95 | 0.0001* |
| Total insulin infused during DKA (units) | 91.6 (54.5–143.9) | 90.2 (53.6–157.4) | 0.5551 |
| Hypoglycemic episodes (n) | 0 (0–1); 556 | 0 (0–0); 173 | 0.0056* |
| Hypokalemic episodes (n) | 0 (0–1); 582 | 0 (0–1); 185 | 0.3229 |
| Hyperkalemic episodes (n) | 0 (0–0); 582 | 0 (0–0); 185 | 0.1356 |
| DKA duration (hours) | 13.9 (9.1–21.9); 581 | 13.9 (7.7–21.1); 185 | 0.4638 |
| Length of hospitalization (days) | 3.0 (1.7–6.1); 576 | 11.0 (5.0–23.1); 183 | <0.0001* |
*P<0.05.
DKA, diabetic ketoacidosis; Q1, first quartile; Q3, third quartile.